LabCompass

Jeffrey L. Dage

Medicine · Indiana University

OpenAlex ORCID
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studiesIntracerebral and Subarachnoid Hemorrhage ResearchFunctional Brain Connectivity Studies

Publications

232

Citations

15,665

Est. group size

—

Recurring co-author estimate

Active years

30

Publishing since 1997

Research summary
AI-generated

Jeffrey L. Dage studies biological markers (biomarkers) of Alzheimer's disease and related brain disorders, focusing on substances measurable in blood and spinal fluid such as tau proteins and amyloid that indicate disease. His work aims to develop and standardize blood tests that can detect and predict Alzheimer's pathology, track disease progression, and support treatment decisions.

Blood-based Alzheimer's biomarkersTau and amyloid protein measurementPET brain imaging correlationBiomarker standardization and validationNeurodegenerative disease diagnosis

Publication activity grew sharply from a few papers per year in the late 2010s to a high and sustained output of roughly 30-40 papers per year since 2021.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 29.2/year recently
2017: 2 publications172018: 5 publications182019: 5 publications192020: 20 publications202021: 35 publications212022: 28 publications222023: 37 publications232024: 42 publications42242025: 35 publications252026: 4 publications26
Recent publications
Publishes in
  • Alzheimer s & Dementia×125
  • medRxiv×13
  • Nature Medicine×8
  • Alzheimer s Research & Therapy×6
  • JAMA Neurology×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile